Thalassemia:
Enhancing Patients’ Disease
Understanding for Improved Outcomes

Insights from the global thalassemia
community to inform strategies for
improving health literacy, disease
understanding, and patient outcomes.

This study and white paper were conducted in collaboration between Agios and a multidisciplinary group of patients, advocates and clinicians founded and funded by Agios. Survey and medical writing support was provided by FleishmanHillard, paid for by Agios Pharmaceuticals, Inc.

Click to download